Shafkat AOM CHC

Embed Size (px)

Citation preview

  • 8/8/2019 Shafkat AOM CHC

    1/29

    Acute Otitis

    Media

    Shafkat Anwar, M.D.Pediatric Resident Level 3

    Childrens National Medical Center

  • 8/8/2019 Shafkat AOM CHC

    2/29

    Objectives

    Definition of AOM

    Pain Management

    Initial Observation vs. Antibacterial treatment Antibiotic Choice

    Preventative Measures

  • 8/8/2019 Shafkat AOM CHC

    3/29

    Background

    Acute otitis media (AOM) is the most commoninfection for which antibacterial agents areprescribed for children in the United States.

    Office visits for OM (was) 16 million in 2000

    802 antibacterial prescriptions per 1000 visits fora total of more than 13 million prescriptions in2000.

    An individual course of antibacterial therapy canrange in cost from $10 to more than $100 3-5

  • 8/8/2019 Shafkat AOM CHC

    4/29

    cope

    Diagnosis and management of uncomplicated AOM.Based on the AAP Policy Statement: Diagnosis andManagement of Acute Otitis Media7

    Ages 2 months to 12 years

    No signs/symptoms of systemic illness unrelated tothe middle ear

    Otherwise healthy child without underlying conditionsthat may alter the natural course of AOM

  • 8/8/2019 Shafkat AOM CHC

    5/29

    Etiology

    Pathogenic bacteria isolated in ~ 6575% ofcases

    Three pathogens predominate:

    Streptococcus pneumoniae (40%)nontypable Haemophilus influenzae (2530%)

    Moraxella catarrhalis (1015%)

    Respiratory viruses may also be found, eitheralone or, more commonly, in association withpathogenic bacteria 6

  • 8/8/2019 Shafkat AOM CHC

    6/29

    Recommendation 1: Diagnosis

    To diagnose AOMthe clinician should:

    confirm a history ofacute onset

    identify signs ofmiddle ear effusion

    evaluate for the presence of signs and

    symptoms ofmiddle-ear inflammation

  • 8/8/2019 Shafkat AOM CHC

    7/29

    Diagnosis

    Recent, usually abrupt and rapid onset of signs andsymptoms of middle-ear inflammation and MEE

    Symptoms include:

    Otalgia, or pulling of the ear in an infant

    Irritability in an infant or toddler

    Otorrhea, and/or fever

    These findings, other than otorrhea, are nonspecificand

    frequently overlap those of an uncomplicated viral URI

    Therefore, clinical history alone is poorly predictive of thepresence of AOM, especially in younger children

  • 8/8/2019 Shafkat AOM CHC

    8/29

    Definition of AOM: Middle Ear Effusion

    The presence of MEE is indicated by any of the following:

    a. Bulging of the tympanic membrane(highest predictive value for the presence of MEE)

    b. Limited or absent mobility of the tympanic membrane

    c. Air-fluid level behind the tympanic membrane

    d. Otorrhea

  • 8/8/2019 Shafkat AOM CHC

    9/29

    Definition of AOM: Middle Ear Inflammation

    Signs or symptoms of middle-ear inflammation is indicated by:

    a. Distinct erythema of the tympanic membrane or

    b. Distinct otalgia: discomfort clearly referable to the ear[s]that results in interference withnormal activity or sleep

  • 8/8/2019 Shafkat AOM CHC

    10/29

    TRANSLATION:

    You have to dig out the earwax!You have to perform pneumatic otoscopy!!

  • 8/8/2019 Shafkat AOM CHC

    11/29

    Pictures are worth 1000 words

    Light Reflex

    TM intact, noeffusion/erythema, nofluid level, no bulge

    Ossicles

  • 8/8/2019 Shafkat AOM CHC

    12/29

    7

  • 8/8/2019 Shafkat AOM CHC

    13/29

    What if the kid is crying up a storm and the TM

    is all red?

    AAP: Redness of the tympanic membrane caused by inflammationmay be present and must be distinguished from the pinkerythematous flush evoked by crying or high fever, which isusually less intense and remits as the child quiets down.

  • 8/8/2019 Shafkat AOM CHC

    14/29

    Recommendation 2: Pain

    The management of AOM should include anassessment of pain. If pain is present, theclinician should recommend treatment to

    reduce pain.

  • 8/8/2019 Shafkat AOM CHC

    15/29

    Recommendation 3A: Observe vs. Treat

    Observation without use of antibacterial agents ina child with uncomplicated AOM is an option forselected children based on:

    diagnostic certainty

    age

    illness severity assurance of follow-up

  • 8/8/2019 Shafkat AOM CHC

    16/29

    Observe v.s.Treat

    Age Certain

    Diagnosis

    Uncertain

    Diagnosis

    < 6 mo Abic tx Abic tx

    6 mo 2 y Abic tx Abic tx if severe illnessor observation if

    nonsevere illness

    > 2 y Abic tx if severeillness or

    observation ifnonsevere illness

    Observation

  • 8/8/2019 Shafkat AOM CHC

    17/29

    oncerns regarding observation

    The likelihood of recovery without antibacterial therapy differsdepending on the severity of signs and symptoms at initialexamination.

    current evidence does not suggest a clinically importantincreased risk of mastoiditis in children when AOM ismanaged only with initial symptomatic treatment without

    antibacterial agents.

  • 8/8/2019 Shafkat AOM CHC

    18/29

    Monitoring and Follow-up is key!

    When considering (observation), the clinician should verifythe presence of an adult who will reliably observe the child,recognize signs of serious illness, and be able to provideprompt access to medical care if improvement does notoccur.

    If there is worsening of illness or if there is no improvement in48 to 72 hours while a child is under observation, institution

    of antibacterial therapy should be considered.

  • 8/8/2019 Shafkat AOM CHC

    19/29

    Recommendation 3B: Antibiotic Choice

    If a decision is made to treat with an

    antibacterial agent, the clinician should

    prescribe ___________ for most children.

    When amoxicillin is used, the dose should be

    ____________________.

    Amoxicillin

    80 to 90 mg/kg per day

  • 8/8/2019 Shafkat AOM CHC

    20/29

    Amoxicillin vs. Augmentin

    In patients who have severe illness (moderate to severeotalgia or fever > 39C) and in those for whom additionalcoverage for -lactamase-positive Haemophilus influenzaeand Moraxella catarrhalis is desired, therapy should beinitiated with high-dose amoxicillin-clavulanate.

    Approximately 50% of isolates ofH flu and 100% of Mcatarrhalis from the upper respiratory tract are likely to be -lactamase (+). ~ 15% to 50% (average: 30%) of upperrespiratory tract isolates ofS pneumoniae are also not

    susceptible to PCN.

  • 8/8/2019 Shafkat AOM CHC

    21/29

  • 8/8/2019 Shafkat AOM CHC

    22/29

    ome Alternatives to Amoxicillin

    If the patient is allergic to amoxicillin and the allergic reactionwas not a type I hypersensitivity reaction (urticaria oranaphylaxis), cefdinir, cefpodoxime, or cefuroxime can beused.

    In cases of type I reactions, azithromycin or clarithromycincan be used.

    Ceftriaxone X 3 consecutive days either IV or IM, can be usedin children with vomiting or situations that preclude

    administration of PO antibiotics.

  • 8/8/2019 Shafkat AOM CHC

    23/29

    Duration of therapy

    For younger children and for children with severe disease, astandard 10-day course is recommended.

    For children 6 years of age and older with mild to moderate

    disease, a 5- to 7-day course is appropriate.

  • 8/8/2019 Shafkat AOM CHC

    24/29

    Recommendation 4: Antibiotic Failure

    If the patient fails to respond to the initialmanagement option within 48-72 hours, reassessthe patient to confirm AOM and exclude othercauses of illness.

    If AOM is confirmed in the patient was initiallymanaged with observation, begin antibacterialtherapy.

    If the patient was initially managed with anantibacterial agent, change the antibacterialagent.

  • 8/8/2019 Shafkat AOM CHC

    25/29

    Antibiotic Failure

    A patient who fails amoxicillin-potassium clavulanate shouldbe treated with a 3-day course of parenteral ceftriaxone.

    If AOM persists, tympanocentesis should be recommendedto make a bacteriologic diagnosis.

    If tympanocentesis is not available, a course of clindamycinmay be considered.

  • 8/8/2019 Shafkat AOM CHC

    26/29

    Recommendation 5: Prevention

    Clinicians should encourage the prevention ofAOMthrough reduction of risk factors

    Administering the influenza vaccine

    reducing the incidence of respiratory tract

    infections by altering child care centerattendance

    implementation of breastfeeding for at least thefirst 6 months, avoiding supine bottle feeding

    reducing or eliminating pacifier use in the second6 months of life

    eliminating exposure to passive tobacco smoke

  • 8/8/2019 Shafkat AOM CHC

    27/29

    Recommendation 6: Complementary tx

    No recommendations for complementary and

    alternative medicine (CAM) for treatment of AOM

    are made based on limited and controversial

    data.

  • 8/8/2019 Shafkat AOM CHC

    28/29

    ummary

    Diagnose AOM

    Manage the pain

    Decide on observation vs. antibacterialtreatment

    Choose an antibiotic

    Monitor and follow up

    Encourage preventative measures

  • 8/8/2019 Shafkat AOM CHC

    29/29

    Works Cited

    1. Niemela M, Uhari M, Jounio-Ervasti K, Luotonen J, Alho OP, Vierimaa E. Lack ofspecific symptomatology in children with acute otitis media.Pediatr Infect Dis J.1994;13 :765 768

    2. Cummings. Acute Otitis Media. Otolaryngology: Head & Neck Surgery, 4th ed.,Copyright 2005 Mosby, Inc. p4451

    3. Schappert SM. Office visits for otitis media: United States, 197590.Adv Data.

    1992;214 :1 184. Cherry DK, Woodwell DA. National ambulatory medical care survey: 2000

    summary.Adv Data. 2002;328 :1 32

    5. McCaig LF, Besser RE, Hughes JM. Trends in antimicrobial prescribing rates forchildren and adolescents.JAMA. 2002;287 :3096 3102

    6. Behrman. Acute Otitis Media. Nelson Textbook of Pediatrics, 17th ed., Copyright 2004 Saunders, An Imprint of Elsevier. P2138

    7. Friedman, N. Selective use of antibiotics in acute otitis media. Pediatric Infectious

    Disease Journal. 2006 Feb;25(2):101-7.

    8. AAP Subcommittee on Management of Acute Otitis Media. Clinical PracticeGuideline. Pediatrics Vol. 133 No. 5, May 2004